Daljit Singh Aurora - 18 Feb 2025 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Signature
/s/ Michael Milligan, as Attorney-in-Fact for Daljit Singh Aurora
Issuer symbol
NMRA
Transactions as of
18 Feb 2025
Net transactions value
-$14,347
Form type
4
Filing time
20 Feb 2025, 17:13:14 UTC
Previous filing
18 Feb 2025
Next filing
30 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Sale $14,347 -8,565 -8.8% $1.68 88,935 18 Feb 2025 Direct F1, F2
holding NMRA Common Stock 114,703 18 Feb 2025 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 22, 2024, which provides for the automatic sale of shares of common stock that would otherwise be issuable on each vesting date of a covered restricted stock unit in an amount necessary to satisfy the applicable withholding obligation.
F2 This transaction was executed in multiple trades in prices ranging from $1.66 to $1.705, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Shares held by Aurora Family Trust.